Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PET imaging of myocardial aging
The Nhlbi-Bay Area Functional Genomics Consortium
Activation of Hemostasis
Followup Study of A Cohort of Bereaved Partners of Pwas
Structural-Functional Studies of Neutrophil Activation
Recently added grants:
Assessment of EEG Responses to Spinal Cord Stimulation Waveforms in Chronic Pain Patients
The Role of the Tau in Homeostatic Scaling and Mechanisms of Alzheimer's Disease
Risk factors associated with the prevalence of Peri-Implantitis disease
Defining the genetic landscape of nanophthalmos and the role of MYRF
Neuroscientific Exploration of Cultural Protective Factors in American Indians
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-002
Application #
6828860
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant